Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells
Authors
Keywords
-
Journal
CANCER
Volume 117, Issue 13, Pages 2926-2938
Publisher
Wiley
Online
2011-01-11
DOI
10.1002/cncr.25868
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
- (2010) I. Ben Sahra et al. CANCER RESEARCH
- Targeting the Warburg effect in hematological malignancies: from PET to therapy
- (2010) Mala Shanmugam et al. CURRENT OPINION IN ONCOLOGY
- Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
- (2009) Cherry L Estilo et al. BMC CANCER
- Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling
- (2009) C. Yang et al. CANCER RESEARCH
- The molecular determinants of de novo nucleotide biosynthesis in cancer cells
- (2009) Xuemei Tong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: Present status and future prospects
- (2009) BS Dwarakanath et al. Journal of Cancer Research and Therapeutics
- MYCgene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients
- (2009) N. Bhattacharya et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Ovarian carcinoma cells with low levels of -F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment
- (2009) E. Hernlund et al. MOLECULAR CANCER THERAPEUTICS
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
- (2009) Arun Sreekumar et al. NATURE
- KEGG for representation and analysis of molecular networks involving diseases and drugs
- (2009) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
- (2009) Jean-Pierre Pignon et al. RADIOTHERAPY AND ONCOLOGY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells
- (2008) P. Hamel et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells
- (2008) Thomas McFate et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer
- (2008) Juergen Ervens et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs
- (2008) Linda Strandberg Ihrlund et al. Molecular Oncology
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
- (2008) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now